A detailed history of Walker Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Walker Asset Management, LLC holds 683 shares of LLY stock, worth $510,890. This represents 0.41% of its overall portfolio holdings.

Number of Shares
683
Previous 654 4.43%
Holding current value
$510,890
Previous $592,000 2.2%
% of portfolio
0.41%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $22,392 - $27,840
29 Added 4.43%
683 $605,000
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $35,518 - $44,542
-49 Reduced 6.97%
654 $592,000
Q1 2024

Apr 10, 2024

SELL
$592.2 - $792.28 $36,124 - $48,329
-61 Reduced 7.98%
703 $546,000
Q4 2023

Jan 08, 2024

BUY
$525.19 - $619.13 $401,245 - $473,015
764 New
764 $445,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Walker Asset Management, LLC Portfolio

Follow Walker Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walker Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walker Asset Management, LLC with notifications on news.